关注今日：90 | 主题：507513
微信扫一扫
扫一扫，下载丁香园 App
即送15丁当
【求助】谁那里有SCI的期刊目录，谢谢
页码直达：
这个帖子发布于7年零353天前，其中的信息可能已发生改变或有所发展。
Bioorganic & Medicinal Chemistry Letters不知道这个杂志是不是SCI能不能给传个SCI的目录，谢谢
不知道邀请谁？试试他们
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
丁香园荣誉版主
wzhan1985 Bioorganic & Medicinal Chemistry Letters不知道这个杂志是不是SCI能不能给传个SCI的目录，谢谢是的，if=2.602，英国的，半月刊:)
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
谢谢，还有个问题，这个杂志的稿约在哪里找？我第一次写英文的文献，想投这个杂志的！！
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
丁香园荣誉版主
wzhan1985 谢谢，还有个问题，这个杂志的稿约在哪里找？我第一次写英文的文献，想投这个杂志的！！
Guide for Authors Summary of Instructions to Authors Submission Checklist Journal Title Abbreviation List Bioorganic & Medicinal Chemistry Letters publishes research results of outstanding significance and timeliness in the fields of medicinal chemistry, chemical biology, bioorganic chemistry, bioinorganic chemistry, and related disciplines. Articles are in the form of communications reporting experimental or theoretical results of special interest.Manuscript submission Online submission: Authors should submit their manuscript to the appropriate regional editor (see below) via the online submission page of this journal at
Authors will be guided stepwise through the creation and uploading of the various files. The system automatically converts source files to a single Adobe Acrobat PDF version of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted to PDF at submission for the review process, these source files are needed for further processing after acceptance. All correspondence, including notification of the editor's decision and requests for revision, takes place by e-mail and via the author's home page. A printed copy of the manuscript is not required at any stage of the process.The following items should be supplied:o Manuscript. It is not necessary to embed graphics in the text, but if you do so please note that separate graphic files will always be required for proof production when a manuscript is accepted for publication. Graphics should be submitted as separate, high-resolution artwork files. These will be automatically incorporated into the single PDF that the system creates for review.o Graphical abstract for the contents list (submitted as a separate document).o Cover letter (i) highlighting the novelty, significance, and urgency of the submitted work that meri (ii) providing details of other relevant information, e.g., submitted or in press manuscripts.o Names of potential referees.Manuscripts should be addressed to the appropriate regional editor: Submissions from Japan and other Asian countries: Professor Masakatsu Shibasaki, Japanese Regional Editor, Graduate School of Pharmaceutical Sciences, The University of Tokyo, JapanSubmissions from Europe: Professor Stephen Neidle, Cancer Research UK Professorial Fellow and Professor of Chemical Biology, The School of Pharmacy, University of London, UK Submissions from USA, Canada, and all others: Professor Dale L. Boger, Editor-in-Chief, The Scripps Research Institute, La Jolla, CA, USAAll manuscripts will be centrally handled by the journal editorial office, which will forward manuscripts to the regional editors:Editorial OfficeBioorganic & Medicinal Chemistry Letters 525 B Street, Suite 1900San Diego, CA , USAFacsimile: (1) 619-699-6801E-mail: bmcl- Authors who are unable to submit their paper online should contact the editorial office prior to submission at the above address.Language: Articles must be written in clear, concise, grammatical English. Any author who is not fluent in idiomatic English is urged to gain assistance with manuscript preparation. Reviewers are not expected to correct grammatical errors and any deficiency in this area may detract from the scientific content of the paper.Language editing: International Science Editing and Asia Science Editing can provide English language and copyediting services to authors who want to publish in scientific, technical, and medical journals and need assistance before they submit their article or before it is accepted for publication. Authors can contact these services directly: International Science Editing (
and Asia Science Editing (
or, for more information about language editing services, authors may contact
who will be happy to deal with any questions. Please note Elsevier neither endorses nor takes responsibility for any products, goods, or services offered by outside vendors through our services or in any advertising. For more information please refer to our terms and conditions at
Journal policy: Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without the written consent of the publisher. Authors accept full responsibility for the factual accuracy of the data presented and should obtain any authorization necessary for publication. As such the contents of the papers are the sole responsibility of the authors and publication shall not imply the concurrence of the editors or publisher.All papers are submitted to referees who advise the editor on the matter of acceptance in accordance with the high standards required, on the understanding that the subject matter has not been previously published and is not under consideration elsewhere. Referees will be asked to distinguish contributions meeting the above requirements and having an element of novelty, timeliness, and urgency that merits publication in the journal. We ask referees to help in the selection of articles that have this breadth and suggest that papers covering narrower aspects of the field be sent to journals specializing in those areas. Referees' names are not disclosed, but their views are forwarded by the editor to the authors for consideration. Authors are encouraged to suggest names of several experts in the field when papers are first submitted or at any time in the evaluation process.Copyright guidelines: Upon acceptance of an article, authors will be asked to transfer copyright (for more information on copyright see
This transfer will ensure the widest possible dissemination of information. A letter will be sent to the corresponding author confirming receipt of the manuscript. A form facilitating transfer of copyright will be provided. If material from other copyrighted works is included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases, which can be obtained at
see under &Copyright information&.Manuscript preparation General requirements: The article including artwork can be no longer than four printed pages and the approximate maximum word count per page is 700 words. Pages must be numbered. The corresponding author's full mailing address, phone and fax numbers, and e-mail address should be included. The manuscript should be compiled in the following order: Graphical Abstract, Title, Authors, Affiliations, Abstract, Text, Acknowledgments, References and notes, Tables, Legends, Figures, and Schemes.Templates: Templates are provided to allow authors to view their paper in a style close to the final printed form. Their use is optional. All manuscripts will be fully typeset from the author's electronic files. It should be noted that due to defined typesetting standards and the complex requirements of electronic publishing, the publisher will not always be able to exactly match the layout the author has submitted. In particular, in the finished journal article, figures and tables are usually placed at the top or bottom of pages. The template is only intended to be used in assisting with the preparation and submission of manuscripts.It should be noted that use of the journal templates is not a requirement and their adoption will neither speed nor delay publication. Elsevier can handle most major word processing packages and in general most formatting applied by authors for style and layout is replaced when the article is being typeset.These templates contain a large number of macros. To ensure successful PDF conversion during online submission, it is important that the author save a new document based on the template, rather than saving the template itself. To use the template, the author should save the final document as a Word file with a '.doc' extension (rather than the '.dot' extension).The templates can be found at
Graphical abstracts: Authors must supply a graphical abstract at the time the paper is first submitted. The abstract should summarize the contents of the paper in a concise, pictorial form designed to capture the attention of a wide readership and for compilation of databases. Carefully drawn chemical structures that serve to illustrate the theme of the paper are desired. Authors may also provide appropriate text, not exceeding 30 words.The content of the graphical abstract will be typeset and should be kept within an area of 5 cm by 17 cm. Authors must supply the graphic separately as an electronic file.For examples of graphical abstracts, please consult a recent issue of the journal or visit the journal page on ScienceDirect at
and click 'Sample Issue Online'.Title: The title should be brief, specific, and rich
it should not contain any literature references or compound numbers.Authors and affiliations: Where possible, supply given names, middle initials, and family names for complete identification. Use superscript lowercase letters to indicate different addresses, which should be as detailed as possible, and must include the country name. The corresponding author should be indicated with an asterisk, and contact details (fax, e-mail) may be placed in a footnote. Information relating to other authors (e.g., present addresses) should be placed in footnotes indicated by the appropriate symbols (see below).Abstracts: Authors must include a short abstract that states briefly the purpose of the research, the principal results, and major conclusions. References should not be mentioned in the abstract unless full details are given.Text: Text should either not be subdivided or done so in the simplest possible way consistent with clarity. Headings should be used sparingly. Common headings such as 'Introduction' and 'Results and discussion' should not be used, as the text within these sections should be self explanatory. As such, the publisher recommends that only the 'Acknowledgments' and 'References and notes' headings be used. In the introductory section of the communication, the author should strive to define the significance of the work and the justification for its rapid publication. Ensure that all tables, figures, and schemes are cited in the text in numerical order. The preferred position for chemical structures should be indicated. Trade names should have an initial capital letter, and trademark protection should be acknowledged in the standard fashion. All measurements and data should be given in SI units where possible, or other internationally accepted units. Authors are requested to draw attention to hazardous materials or procedures by adding the word CAUTION followed by a brief descriptive phrase and literature references if appropriate. The experimental information should be as concise as possible, while containing all the information necessary to guarantee reproducibility.Abbreviations: Standard ACS abbreviations should be used throughout the manuscript and are employed without periods. The preferred forms for some of the more commonly used abbreviations are mp, bp, °C, K, min, h, mL, μL, g, mg, μg, cm, mm, nm, mol, mmol, μmol, M, mM, μM, ppm, HPLC, TLC, GC, 1H NMR, GC-MS, HRMS, FABHRMS, UV, IR, EPR, ESR, DNase, ED50, ID50, IC50, LD50, im, ip, iv, mRNA, RNase, rRNA, tRNA, cpm, Ci, dpm, V max, K m, k, t 1/2. All non-standard abbreviations should be defined following the first use of the abbreviation. For a detailed listing of standard abbreviations, see The ACS Style G American Chemical Society: Washington, DC, 1997References and notes: In the text, references should be indicated by superscript Arabic numerals which run consecutively through the paper and appear after any punctuation. Please ensure that all references are cited in the text and vice versa. The reference list should preferably contain only literature references though other information (e.g., experimental details) can be placed in this section. Preferably, each reference should contain only one literature citation. Authors are expected to check the original source reference for accuracy. Journal titles should be abbreviated according to American Chemical Society guidelines (The ACS Style G Dodd, J. S., Ed.; American Chemical Society: Washington, DC, 1997). A list of currently accepted journal abbreviations may be found at
Formatting for common references is shown below. Scientific articles: 1. Barton, D. H. R.; Yadav-Bhatnagar, N.; Finet, J.-P.; Khamsi, J. Tetrahedron Lett. 11.Books with editor: 2. Doe, J. S.; Smith, J. J. In Medicinal C Roe, P., Small, J. K., Eds.; Pergamon: Oxford, 1990; Vol. 1, pp 301 383.Books without editor:3. Doe, J. S.; Smith, J. J. Bioorganic C Pergamon: Oxford, 1990, Chapter 6.Theses: 4. Doe, J. S. Ph.D. Thesis, University of California at San Diego, January 2000.Patent/Chem. Abstract: 5. Lyle, F. R. U.S. Patent 6,973,257, 1995; Chem. Abstr. , 2870.Abstract of meeting papers: 6. Doe, J. S. Abstract of Papers, 195th National Meeting of the American Chemical Society, Anaheim, CA; American Chemical Society: Washington, DC, 1995; Abstract 3028.Material presented orally:7. Doe, J. S. Presented at the 195th National Meeting of the American Chemical Society, Anaheim, CA, March 1995; paper 205. Footnotes: Footnotes should appear at the bottom of the appropriate page and be indicated by the following symbols: asterisk, dagger, double dagger,section sign, paragraph symbol, parallels.Tables: All tables should be cited in the text, and numbered in order of appearance with Arabic numerals. All table columns should have a brief explanatory heading and, where appropriate, units of measurement. Vertical lines should not be used. Footnotes to tables should be typed below the table and should be referred to by superscript letters.Artwork: Figures, schemes, and equations must be cited in the text and numbered in order of appearance with Arabic numerals. Other graphics, such as structures, do not need to be numbered, but please indicate in the text where these are to appear. All graphics (including chemical structures) must be provided at the actual size that they are to appear (single-column width is 8.4 cm, double-column width is 17.7 cm). Please arrange schematics so that they fill the column space (either single or double), so as not to leave a lot of unused white space. Please ensure that all illustrations within a paper are consistent in type, quality and size. Captions should not be included as instead all captions should be supplied at the end of the text. Reagents and conditions (unless incorporated into the actual schematic) should also be provided as text. All graphics must be labeled with the figure or scheme number, and the corresponding author's name.To help authors provide actual size graphics, it is suggested that the following settings be used with CSC ChemDraw and ISIS Draw: Font 10 pt Helvetica, chain angle 120°, bond spacing 18% of length, fixed length 10.08 pt (0.354 cm), bold width 1.4 pt (0.049 cm), line width 0.42 pt (0.015 cm), margin width 1.12 pt (0.040 cm), and hash spacing 1.75 pt (0.062 cm). Compound numbers should be in boldface. In order to accurately design schematics to print out at the proper width, the original drawing cannot exceed a column width of 8.4 cm (for single column) and 17.7 cm (for double column). Layout design is facilitated if authors submit their original artwork in the actual size to be published. Please save graphics as an Encapsulated PostScript file (EPS) or a Tagged Image File Format (TIFF), as well as the program the graphic was originally drawn in. For more details on the preparation and submission of artwork, please visit
Color: Color figures should be supplied in electronic format as JPEG files (minimum 300 dots per inch).In print: Color figures may be printed in the journal at no charge to the author, provided that the editor considers the color necessary to convey scientific information. On the web: Any figure can appear free of charge in color in the web version of your article (e.g., on ScienceDirect), regardless of whether it is reproduced in color in the printed version. Please note that if you do not opt for color in print, you should submit relevant figures in both color (for the web) and black and white (for print).Journal conventions Nomenclature: It is the responsibility of the authors to provide correct nomenclature. Chemical names for drugs are preferred. If these are not practical, generic names, names approved by the U.S. Adopted Names Council, or those approved by the World Health Organization may be used. If a generic name is used, its chemical name or structure should be provided at the point of first citation. Authors will find the following as useful reference books for recommended nomenclature:IUPAC Nomenclature of Organic C Rigaudy, J., Klesney, S. P., Eds.; Pergamon: Oxford, 1979.Enzyme N Webb, E. C., Ed.; Academic: Orlando, 1992.Biochemical Nomenclature and Related D The Biochemistry Society: London, 1978.The ACS Style G Dodd, J. S., Ed.; American Chemical Society: Washington, DC, 1997.X-ray crystallographic data: Prior to submission of the manuscript, the author should deposit crystallographic data for organic and metalorganic structures with the Cambridge Crystallographic Data Centre. The data, without structure factors, should be sent by e-mail to deposit@ccdc.cam ac.uk, as an ASCII file, preferably in CIF format. Hard-copy data should be sent to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK. A checklist of data items for deposition can be obtained from the CCDC Home Page on the World Wide Web (
or by e-mail to fileserv@ccdc.cam.ac.uk, with the one-line message, sendme checklist. The data will be acknowledged, within three working days, with one CCDC deposition number per structure deposited. These numbers should be included with the following standard text in the manuscript: Crystallographic data (excluding structure factors) for the structures in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication numbers CCDC. . . Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44 (0) or e-mail: deposit@ccdc.cam.ac.uk]. Deposited data may be accessed by the journal and checked as part of the refereeing process. If data are revised prior to publication, a replacement file should be sent to CCDC.Biological data: Biological test methods must be referenced or described in sufficient detail to permit the experiments to be repeated by others. Standard compounds and established drugs should be tested in the same system for comparison. Statistical limits (statistical significance) for the biological data are usually required. If statistical limits cannot be provided, the number of determinations and an indication of the variability and reliability of the results should be given. Doses and concentrations should be expressed in molar quantities when comparisons of potencies are made with compounds having substantial differences in molecular weights. For inactive agents, the highest concentration or dose level tested should be indicated. For optically active substances, the optical purity should be clearly documented (% ee, % de), especially for the less active or inactive enantiomers or diastereomers. In such instances, the optical purity must be documented (% ee, % de) in a way that distinguishes or accommodates potential contamination by the most active enantiomer.Structural data: Atomic coordinates for structures of biological macromolecules determined by X-ray, NMR, or other methods should be deposited with the RCSB Protein Data Bank (PDB). It is the responsibility of the author to obtain a file name f the file name must be referenced in the manuscript. Deposition (deposit.pdb.org) and release information are available at
Manuscripts will be sent out for review only after receiving a written statement from the author that the coordinates will be deposited. If a manuscript is accepted for publication, and the PDB file name has not yet been obtained, it must be added prior to publication. Upon written request by the author, the PDB will refer requests for coordinates to the originating author, but one year after publication, they will be made generally available upon request. Please address all inquiries about depositing to the PDB.GenBank/DNA sequence linking: Authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these sources, should type this information in the following manner: For each and every accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalized (see example below.) This combination of letters and format will enable the typesetter to recognize the relevant texts as accession numbers and add the required link to GenBank's sequences. Example: GenBank accession nos. AI631510 , AI631511 , AI632198 , and BF223228 ), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048 ), and a T-cell lymphoma (GenBank accession no. AA361117 ).Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can result in a dead link.In the final version of the printed article, the accession number text will not appear bold or underlined. In the final version of the electronic copy, the accession number text will be linked to the appropriate source in the NCBI databases, enabling readers to go directly to that source from the article.Software: Software used as part of computer-aided drug design (e.g., molecular modeling, QSAR, conformational analysis, molecular dynamics) must be specified and should be readily available from accepted sources or the authors may specify where specialized software can be obtained. Assurance of the quality of the parameters employed for the relevant potential functions should be detailed in the manuscript.Supplementary material: Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips, and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier web products, including ScienceDirect:
To ensure that your submitted material is directly usable, please provide data in one of our recommended file formats. Supplementary data must be saved in files separate from those for the manuscript and figures, and all file names must be supplied. Supplementary files should either be referred to from within the text of your manuscript in the same way as for figures or tables, or their presence be indicated by adding a paragraph entitled 'Supplementary data' at the end of the manuscript, detailing which data are supplied. In addition, authors should also provide a concise and descriptive caption for each file.When supplying supplementary data, authors must state whether the data files are either (i) for online publication or (ii) to be used as an aid for the refereeing of the paper only. All supplementary data will be subject to peer review. For more detailed instructions, please visit
Proofs Proofs will be despatched via e-mail by the publisher and should be returned with corrections as quickly as possible, normally within 48 hours of receipt. Authors should ensure that corrections are returned in one communication and are complete, as subsequent corrections will not be possible. Any amendments will be incorporated and the final article will then be published online as an Article in Press on ScienceDirect (
Articles in Press take full advantage of the enhanced ScienceDirect functionality, including the ability to be cited. This is possible due the innovative use of the DOI article identifier, which enables the citation of a paper before volume, issue and page numbers are allocated. The Article in Press will be removed once the paper has been assigned to an issue and the issue has been compiled.Corrections If errors of consequence are in a published paper, a correction of the error should be sent to the editor for publication in the journal.Offprints The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail or, alternatively, with twenty-five free paper offprints. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use. Page charges None.Author benefits Contributors to Elsevier journals are entitled to a 30% discount on all Elsevier books.Other inquiries
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
这是2007年的期刊目录，主要是生物医学方面的，希望对你有所帮助
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
wellyy2005 edited on
这是2007年的期刊目录，主要是生物医学方面的，希望对你有所帮助
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
wellyy2005 edited on
这是2007年的期刊目录，主要是生物医学方面的，希望对你有所帮助
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
wellyy2005 edited on
这是2007年的期刊目录，主要是生物医学方面的，希望对你有所帮助
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
wellyy2005 edited on
这是2007年的期刊目录，主要是生物医学方面的，希望对你有所帮助
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
wellyy2005 edited on
谢谢大家帮助！！！
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
我有一个很实用的东西给大家共享，斑竹要加分呀。呵呵
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
wellyy2005 edited on
丁香园荣誉版主
因涉及知识产权等方面的问题，论文版不提倡发布JCO有关的影响因子信息，请各位站友理解、配合！谢谢！欢迎继续参与专业讨论。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
斑竹，我不要影响因子哦，我要目录，呵呵，我只是想知道哪些杂志是SCI
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
顶一下啊，好像每年都有变化的
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
关于丁香园